Here's a quick few notes from last research (last month).
Latest is the interim results being presented in London on the 25 th May, and then a public webinar on the 29th and 30th May.
Trials:
Cancer: lung, breast, head and nack, ovarian, Melanona
+ 2 results due 'mid 2018' - Phase 1 TACTI (interim results 25th); AIPAC
+ lead products IMP321, IMP761
+ new trial H2 2018 - TACTI 002; FDA approval H1 2018.
+ Chinese parrtners EOL - H1 2018 EFTI trial results
+ Japanese partners CYTLIMIC - phase 1 begun
Will make all that more cohesive later.
- Forums
- ASX - Short Term Trading
- XAO
- Short Term Trading Week Starting: 21 May
Short Term Trading Week Starting: 21 May, page-72
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XAO (ASX) to my watchlist
|
|||||
Last
8,195.2 |
Change
-21.800(0.27%) |
Mkt cap ! n/a |
Open | High | Low |
8,217.0 | 8,229.9 | 8,171.9 |
Featured News
XAO (ASX) Chart |